Calmodulin antagonists decrease glucose 1,6-bisphosphate, fructose 1,6-bisphosphate, ATP and viability of melanoma cells

European Journal of Pharmacology

Volumn 313, Issue 3, 1996, Pages 265-271

  Glass Marmor, Lea ^a   Morgenstern, Haya ^a   Beitner, Rivka ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

ATP; Calmodulin antagonist; Fructose 1,6 bisphosphate (fructose 1,6 P2, Fru 1,6 P2); Glucose 1,6 bisphosphate (glucose 1,6 P2, Glc 1,6 P2); Glycolysis; Melanoma

Indexed keywords

ADENOSINE TRIPHOSPHATE; BIFONAZOLE; CALMODULIN INHIBITOR; CLOTRIMAZOLE; FRUCTOSE 1,6 BISPHOSPHATE; GLUCOSE 1,6 BISPHOSPHATE; THIORIDAZINE; ZALDARIDE MALEATE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ENERGY RESOURCE; GLYCOLYSIS; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030591794     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00526-2     Document Type: Article

References (46)

1. Al-Ani, A.M., A.G. Messenger, J. Laury, S.S. Bleehen and S. Mac Neil, 1988, Calcium/calmodulin regulation of the proliferation of human epidermal keratinocytes, dermal fibroblasts and mouse B16 melanoma cells in culture, Br. J. Dermatol. 119, 295.
2. Anthony, F.A., J.C. Dowdy and M.E. Costlow, 1994, Attenuation of ultraviolet radiation-induced edema and erythema with topical calmodulin and protein kinase C inhibitors, Photodermatol. Photoimmunol. Photomed. 10, 227.
3. 2+-mobilizing hormones serotonin, vasopressin, and bradykinin increase mitochondrially bound hexokinase in muscle, Biochem. Med. Metab. Biol. 47, 181.
4. Bauer, H.P., G. Birkel and H.W. Hofer, 1986, The concentration of glucose-1,6-bisphosphate and other regulatory metabolites, and the activities of enzymes of the glycogen metabolism in the perfused rabbit psoas muscle, Int. J. Biochem. 18, 73.
5. Beckner, M.E., M.L. Stracke, L.A. Liotta and E. Schiffmann, 1990, Glycolysis as primary energy source in tumor cell chemotaxis, J. Natl. Cancer Inst. 82, 1836.
6. Beitner, R. 1979, The role of glucose-1,6-diphosphate in the regulation of carbohydrate metabolism in muscle, Trends Biochem. Sci. 4, 228.
7. Beitner, R. 1984, Control of levels of glucose 1,6-bisphosphate, Int. J. Biochem. 16, 579.
8. Beitner, R. 1985, Glucose 1,6-bisphosphate - the regulator of carbohydrate metabolism, in: Regulation of Carbohydrate Metabolism, ed. R. Beitner (CRC Press, Inc., Boca Raton, FL) Vol. I, p. 1.
9. Beitner, R. 1987, Method and composition for the therapeutic and prophylactic treatment of trauma to the skin. U.S. Patent No, 4,654,323; No. 4,777,171 (1988) and No. 4,910,197 (1990).
10. Beitner, R. 1990, Regulation of carbohydrate metabolism by glucose-1,6-bisphosphate in extrahepatic tissues; comparison with fructose-2,6-bisphosphate, Int. J. Biochem. 22, 553.
11. 2+ and calmodulin, Int. J. Biochem. 25, 297.
12. Beitner, R., S. Haberman, J. Nordenberg and T.J. Cohen, 1978, The levels of cyclic GMP and glucose-1,6-diphosphate, and the activity of phosphofructokinase, in muscle from normal and dystrophic mice, Biochim. Biophys. Acta 542, 537.
13. Beitner, R., M. Chen-Zion, Y. Sofer-Bassukevitz, H. Morgenstern and H. Ben-Porat, 1989a, Treatment of frostbite with the calmodulin antagonists thioridazine and trifluoperazine, Gen. Pharmacol. 20, 641.
14. Beitner, R., M. Chen-Zion, Y. Sofer-Bassukevitz, Y. Oster, H. Ben-Porat and H. Morgenstern, 1989b, Therapeutic and prophylactic treatment of skin burns with several calmodulin antagonists, Gen. Pharmacol. 20, 165.
15. Beitner, R., M. Chen-Zion and Y. Bassukevitz, 1991, Effect of the calmodulin antagonist CGS 9343B on skin burns, Gen. Pharmacol. 22, 67.
16. Bessman, S.P. 1966, A molecular basis for the mechanism of insulin action, Am. J. Med. 40, 740.
17. Bradford, M.M. 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248.
18. 2 levels in rat skeletal muscle, Biochem. Int. 17, 359.
19. Chen-Zion, M., Y. Bassukevitz and R. Beitner, 1992, Sequence of insulin effects on cytoskeletal and cytosolic phosphofructokinase, mitochondrial hexokinase, glucose 1,6-bisphosphate and fructose 2,6-bisphosphate levels, and the antagonistic action of calmodulin inhibitors, in diaphragm muscle, Int. J. Biochem. 24, 1661.
20. 2+ on binding of the glycolytic enzymes, phosphofructokinase and aldolase, to muscle cytoskeleton, Biochem. Med. Metab. Biol. 49, 173.
21. Eigenbrodt, E., P. Fister and M. Reinacher, 1985, New perspectives on carbohydrate metabolism in tumor cells, in: Regulation of Carbohydrate Metabolism, ed. R. Beitner (CRC Press, Boca Raton, FL), Vol. II, p. 141.
22. Fiechter, A. and F.K. Gmünder, 1989, Metabolic control of glucose degradation in yeast and tumor cells, Adv. Biochem. Eng. Biotechnol. 39, 1.
23. Ford, J.M., W.C. Prozialeck and W.N. Hait, 1989, Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance, Mol. Pharmacol. 35, 105.
24. Greiner, E.F., M. Guppy and K. Brand, 1994, Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production, J. Biol. Chem. 269, 31484.
25. Hait, W.N. and G.L. Lee, 1985, Characteristics of the cytotoxic effects of the phenothiazine class of calmodulin antagonists, Biochem. Pharmacol. 34, 3973.
26. Hait, W.N. and J.S. Lazo, 1986, Calmodulin: a potential target for cancer chemotherapeutic agents, J. Clin. Oncol. 4, 994.
27. Hait, W.N., J.F. Gesmonde and J.S. Lazo, 1994, Effect of anti-calmodulin drugs on the growth and sensitivity of C6 rat glioma cells to bleomycin, Anticancer Res. 14, 1711.
28. Hegemann, L., S.M. Toso, K.I. Lahijani, G.F. Webster and J. Uitto, 1993, Direct interaction of antifungal azole-derivatives with calmodulin: a possible mechanism for their therapeutic activity, J. Invest. Dermatol. 100, 343.
29. Hofer, H.W. and D. Pette, 1968, Wirkungen und Wechselwirkungen von Substraten und Effektoren an der Phosphofructokinase des Kaninchen-Skeletmuskels, Hoppe Seyler's Z. Physiol. Chem. 349, 1378.
30. Ito, H. and H. Hidaka, 1983, Antitumor effect of calmodulin antagonist against MH-134 hepatoma, Ehrlich ascites carcinoma and B-16 melanocarcinoma in mice, Eur. J. Cancer Clin. Oncol. 19, 1183.
31. Katz, A., B.L. Nyomba and C. Bogardus, 1989, Euglycemic hyperinsulinemia increases glucose-1,6-bisphosphate in human skeletal muscle, Int. J. Biochem. 21, 1079.
32. Livnat, T., M. Chen-Zion and R. Beitner, 1993, Stimulatory effect of epidermal growth factor on binding of glycolytic enzymes to muscle cytoskeleton and the antagonistic action of calmodulin inhibitors, Biochem. Med. Metab. Biol. 50, 24.
33. Livnat, T., M. Chen-Zion and R. Beitner, 1994, Platelet-derived growth factor (PDGF) rapidly stimulates binding of glycolytic enzymes to muscle cytoskeleton, prevented by calmodulin antagonists, Biochem. Med. Metab. Biol. 53, 28.
34. Livnat, T., M. Chen-Zion, C. Brodie and R. Beitner, 1995, Rapid stimulatory effect of insulin on binding of glycolytic enzymes to cytoskeleton of C-6 glial cells, and the antagonistic action of calmodulin inhibitors, Endocrine 3, 319.
35. Lowry, O.H., J.V. Passonneau, F.X. Hasselberger and D.W. Schulz, 1964, Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain, J. Biol. Chem. 239, 18.
36. Mac Neil, S., S.W. Walker, H.J. Senior, S.S. Bleehen and S. Tomlinson, 1984, Effects of extracellular calmodulin and calmodulin antagonists on B16 melanoma cell growth, J. Invest. Dermatol. 83, 15.
37. Mac Neil, S., R.A. Dawson, G. Crocker, W.F.G. Tucker, B. Bittiner, J.G. Singleton, T. Hunter and D.F. Tierney, 1993, Antiproliferative effects on keratinocytes of a range of clinically used drugs with calmodulin antagonist activity, Br. J. Dermatol. 128, 143.
38. Mannhold, R. and H. Timmerman, 1992, Putative therapeutic applications of calmodulin antagonists, Pharm. Weekbl. [Sci.] 14, 161.
39. Mohan, C., P.J. Geiger and S.P. Bessman, 1989, The intracellular site of action of insulin: the mitochondrial Krebs cycle, in: Current Topics in Cellular Regulation, eds. B.L. Horecker and E.R. Stadtman (Academic Press, New York) p. 105.
40. Norman, J.A., J. Ansell, G.A. Stone, L.P. Wennogle and J.W.F. Wasley, 1987, CGS 9343B, a novel, potent, and selective inhibitor of calmodulin activity, Mol. Pharmacol. 31, 535.
41. Passonneau, J.V., O.H. Lowry, D.W. Schulz and J.G. Brown, 1969, Glucose 1,6-diphosphate formation by phosphoglucomutase in mammalian tissues, J. Biol. Chem. 244, 902.
42. Rasmussen, C.D. and A.R. Means, 1987, Calmodulin is involved in regulation of cell proliferation, EMBO J. 6, 3961.
43. 1 → S transition of mammalian cells, J. Cell. Biochem. 54, 379.
44. Susuki, N., T. Kanno, Y. Nagata and T. Kato, 1986, Inhibition of proliferative growth in glioma cells by calmodulin antagonists, J. Neurosurg. 65, 74.
45. Veigl, M.L., T.C. Vanaman and W.D. Sedwick, 1984, Calcium and calmodulin in cell growth and transformation, Biochim. Biophys. Acta 738, 21.
46. Viitanen, P.V., P.J. Geiger, S. Erickson-Viitanen and S.P. Bessman, 1984, Evidence for functional hexokinase compartmentation in rat skeletal muscle mitochondria, J. Biol. Chem. 259, 9679.